Resistance to Imidazoles and Triazoles in Saccharomyces cerevisiae as a New Dominant Marker

The imidazole and triazole fungicides inhibit cytochrome P450 14α-lanosterol demethylase (P450 14DM) implicated in the ergosterol biosynthesis pathway, which is specific to fungi and yeasts. Two plasmids were obtained which allow triazole and imidazole resistance in Saccharomyces cerevisiae . The lo...

Full description

Saved in:
Bibliographic Details
Published inPlasmid Vol. 30; no. 3; pp. 224 - 233
Main Authors Doignon, François, Aigle, Michel, Ribereau-Gayon, Pascal
Format Journal Article
LanguageEnglish
Published San Diego, CA Elsevier Inc 01.11.1993
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The imidazole and triazole fungicides inhibit cytochrome P450 14α-lanosterol demethylase (P450 14DM) implicated in the ergosterol biosynthesis pathway, which is specific to fungi and yeasts. Two plasmids were obtained which allow triazole and imidazole resistance in Saccharomyces cerevisiae . The low copy number plasmid (pFD 383) encodes cytochrome P450 C14α lanosterol demethylase under the control of phospho-glycerate-kinase promoter. S. cerevisiae transformed by the pFD 383 plasmid are resistant to imidazoles and triazoles. Moreover, this transformed strain shows increased levels of P450 14DM mRNA and of cytochrome P450. A second low copy number plasmid (pFD 384) carries a mutant cytochrome P450 14α lanosterol demethylase gene, which increases imidazole and triazole resistance. These constructions can be used on a dominant selection marker to transform wild-type yeasts and to confer imidazole and triazole resistance in industrial fermentation.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0147-619X
1095-9890
DOI:10.1006/plas.1993.1054